Background In selecting patients with acute myocardial infarction for thrombolytic therapy, it is important to identify patients who are at high risk for intracranial hemorrhage, for whom thrombolytic therapy is ill advised. We hypothesized that presenting pulse blood pressure, representing the "hammer" effect on cerebral vessels and the effects of age on arterial compliance, might predict thrombolysis-related intracranial hemorrhage better than systolic, diastolic, or mean arterial blood pressures.
Presenting Pulse Pressure Predicts Thrombolytic
Therapy-Related Intracranial Hemorrhage
Background In selecting patients with acute myocardial infarction for thrombolytic therapy, it is important to identify patients who are at high risk for intracranial hemorrhage, for whom thrombolytic therapy is ill advised. We hypothesized that presenting pulse blood pressure, representing the "hammer" effect on cerebral vessels and the effects of age on arterial compliance, might predict thrombolysis-related intracranial hemorrhage better than systolic, diastolic, or mean arterial blood pressures.
Methods and Results Of 3483 Thrombolytic Predictive Instrument (TPI) Project subjects receiving thrombolytic therapy for acute infarction, we identified and obtained detailed clinical data on the 19 with treatment-related intracranial hemorrhages confirmed by computed tomography and on 175 matched controls. Systolic, diastolic, mean arterial, and pulse blood pressures were each significantly related to the occurrence of intracranial hemorrhage, with pulse pressure most highly related. The mean pulse pressure in patients who developed intracranial hemorrhage was 63 mm Hg, 34% higher than the 47 mm Hg mean value for those not developing hemorrhage (P=.0001). Excess pulse pressure, defined as the extent to which a patient's pulse pressure exceeded 40 mm Hg for systolic blood pressures of at least 120 mm Hg, was even more strongly related: its mean value of 23 mm Hg for patients was 130% higher than its mean value of 10 mm Hg for controls (P<.0001). With logistic regression models to estimate the relative risks (odds ratios)
A major concern in the use of thrombolytic therapy for treatment of acute myocardial infarction is the occurrence of intracranial hemorrhage and its devastating consequences. Because of this fear, many patients who would likely benefit are not treated.'
Correspondence to Harry P. Selker for intracranial hemorrhage conferred by each form of blood pressure, the relative risk for hemorrhage was greatest for excess pulse pressure: for each 10-point pulse pressure excess, the relative risk for intracranial hemorrhage was increased by 1.85 
Study Subjects and Data Collection
In addition to the originally collected clinical trial data, to get detailed additional information that might provide clues as to the key risk factors for thrombolysis-related stroke, we performed detailed medical record reviews at 35 hospitals for all thrombolysis-treated patients with a stroke (59) and for 215 randomly selected control subjects who were selected based on the following rationale. To maximize the statistical power of the analysis of the limited number of stroke patients, control subjects were matched to patients on a 4:1 basis. Because quality of care or other practice differences at different hospitals might relate to the likelihood of thrombolysis-related stroke, for each stroke patient, four control subjects were randomly selected from the same hospital. When all cases were reviewed by the Stroke Review Committee, a number of patients designated as having a stroke in their original study were found not to have had intracranial hemorrhages and thus were eliminated. For a small number of patients, there were not four control subjects available at the same hospital, resulting in 215 control subjects rather than the projected 236 (4x59). Because fewer than half of the initial cases had confirmed intracranial hemorrhages by the Stroke Review Committee (see "Results"), the final ratio of control subjects to patients was still greater than 4:1.
A specially trained and experienced nurse-reviewer or nonnurse-reviewer retrieved records at each site, including computed tomography (CT), magnetic resonance imaging (MRI), and other key test reports using a data collection form and manual developed to ensure uniform data collection. The form contained items on patient history, including stroke, head trauma, headache, and seizures; initial and subsequent vital signs; laboratory results (eg, prothrombin time); blood products given; and medication changes (eg, heparin discontinued) before neurological changes. 
Statistical Analysis
To compare the characteristics of patients with intracranial hemorrhage versus those without, we used two-tailed t tests and X2 tests with no continuity correction.8 Logistic regression analyses were used to construct multivariable models using PROC LOGISTIC in SAS, and receiver-operating characteristic (ROC) curve areas were derived from the c-statistic given in the SAS output, which is equivalent to the use of the Wilcoxon statistic.9 Odds ratios and 95% confidence intervals (CIs) for the model variables were based on the parameter estimates and asymptotic standard errors. P values were based on the asymptotic normal distribution of the Wald statistic (the ratio of the parameter estimate to its standard error).
Results

Patient and Stroke Characteristics
After a thorough search of the 3483 patients who were receiving thrombolytic therapy among the 4911 TPI Project subjects, medical records and CT confirmation were obtained on 58 of 59 thrombolytic therapytreated subjects designated as having had a stroke in their original study's database. Of these, 9 were found by review of additional data to not have had a stroke. Of the 49 confirmed strokes, representing 1.4% of thrombolysis-treated patients, 24 were identified as intracranial hemorrhage and 25 as ischemic. Four of the 24 hemorrhages were excluded from our analysis because these patients had suffered some form of previous head injury and probably should not have received thrombolytic therapy; 1 was excluded due to unavailability of the medical record (however, an intracranial hemorrhage was confirmed by the radiology department's CT scan report thrombolytic therapy or had incomplete data or records, leaving 175 for this analysis. The mean age of the patients with intracranial hemorrhage, 64 years, was 7 years greater than the control subjects' mean age of 57 years (P=.006), whereas the two groups were similar in their being predominantly male (NS) and just more than one third had a history of hypertension (NS) ( Table 1 ). The mortality rate for patients with intracranial hemorrhage was 58% compared with 6% for control subjects (P<.0001).
Blood Pressure and Intracranial Hemorrhage
As shown in Table 1 , patients with intracranial hemorrhage had higher initial blood pressure by all measures at hospital presentation (pretreatment and preintracranial hemorrhage) than those without hemorrhage. Their mean systolic blood pressure was 20 mm Hg (15%) higher (P=.001), diastolic pressure was 4 mm Hg (5%) higher (P=.3), mean arterial pressure was 12 mm Hg (11%) higher (P=.01), and pulse pressure was 16 mm Hg (34%) higher (P=.0001). Their excess pulse pressure (as defined in "Methods") was 13 mm Hg (130%) higher (P<.0001) than those without intracranial hemorrhages.
Multivariable logistic regression showed age and blood pressure to be most highly predictive of intracranial hemorrhage. To compare the predictive power of the different measures of blood pressure a priori considered to be potentially important, we tested the blood pressure variables and age in a series of logistic regressions, the final one of which is in Table 2 and is illustrated in the Figure. In and medical record data on the 3483 patients receiving n. This study thrombolytic therapy in the TPI Database, we were able increasing or to definitively confirm intracranial hemorrhage in 24 n. Its univaripatients (and ischemic stroke in 25 patients). This n the findings study's overall 1.4% incidence of stroke among throm-,e and blood bolysis-treated patients, including the 0.7% incidence of thrombolysisintracranial hemorrhages studied in detail, are consistent with the findings of others.' 114 Indeed, although the Ire have been number of intracranial hemorrhages in this study is ir thrombolyrelatively small, it is among the largest groups of thromhypothesized bolytic therapy-related intracranial hemorrhages rerticularly imported and, we believe, the largest group reported with ct of age in the uniform degree of clinical confirmation described the pressure herein. Nevertheless, this study's results need confirmaircumstances tion by other and larger studies. Moreover, larger ng. Furtherstudies should allow study of differences in stroke rates pressure, the related to the use of specific agents. If the importance of "normal" 40 pulse pressure is so confirmed, it would deserve consid-eration in pathophysiological models of intracranial hemorrhage.
Intracranial hemorrhage related to thrombolytic therapy can be devastating, as demonstrated by a hospital mortality rate of 58%, nearly 10 times that of matched control subjects. Therefore, the ability to more accurately predict the occurrence of this complication, to make more informed trade-offs in real-time clinical practice, is potentially valuable. For this purpose, excess pulse blood pressure, particularly its combination with age, as represented by our predictive model, holds promise. Indeed, the predictive performance of this simple model has potential use in the clinical setting.7
